Immucor Blood Bank Products Available to Intalere Members through New Agreement
St. Louis (October 14, 2020) – Intalere, the healthcare industry leader in delivering solutions designed for improved financial, operational and clinical health for our partners, announces a new agreement with Immucor, Inc. for blood bank products.
Through this agreement Intalere members will receive negotiated pricing on Immucor’s blood bank instruments, including Echo Lumena® and NEO Iris®, that provide fast turnaround times, true continuous access and features the broadest test menu available using Immucor’s exclusive Capture® technology for serology-based antibody screening and identification. Additionally, members have access to Immucor’s complete line of serology-based reagents and PreciseType® HEA test, a multiplexed molecular assay that generates detailed molecular information from patient and donor samples, rapidly detecting genotypes for accurate prediction of phenotypes.
This contract is currently effective through September 30, 2023.
About Immucor, Inc.
Immucor is a leading provider of transfusion and transplantation diagnostic products worldwide. Our new corporate identity illustrates the right match of donors with patients in need of blood or an organ as well as Immucor’s partnership with healthcare organizations in need of innovation and productivity. Learn more at www.immucor.com.
Intalere’s mission focuses on elevating the health of healthcare by designing solutions to improve our members’ financial, operational and clinical performance. We empower our customers and deliver measurable results through our highly personalized approach of creating strategies and programs focused on their goals. From managing their entire spend to strategic consulting around diagnosing particular areas of concern, our unique provider led model allows us to leverage nationally recognized best practices in supply chain and patient outcomes to drive efficiencies for our members. To learn more, visit www.intalere.com.